Evidence map›Paper›PMID 25143585›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

CD1d-unrestricted NKT cells are endowed with a hybrid function far superior than that of iNKT cells.

Alexander R Farr, Weisheng Wu, Bongkum Choi, James D Cavalcoli, Yasmina Laouar

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy.Clinical reviews in allergy & immunology · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. CD1d-independent NK1.1Frontiers in immunology · 2022
    Article
  9. Article
  10. Article
  11. STAT5BLeukemia · 2019
    Article
  12. NK1.1 Expression Defines a Population of CD4Frontiers in immunology · 2018
    Article
  13. Review
  14. Transcription factor Bcl11b sustains iNKT1 and iNKT2 cell programs, restricts iNKT17 cell program, and governs iNKT cell survival.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alexander R FarrDepartments of Microbiology and Immunology and.
Weisheng WuComputational Medicine and Bioinformatics, University of Michigan School of Medicine, Ann Arbor, MI 48109.
Bongkum ChoiDepartments of Microbiology and Immunology and.
James D CavalcoliComputational Medicine and Bioinformatics, University of Michigan School of Medicine, Ann Arbor, MI 48109.
Yasmina LaouarDepartments of Microbiology and Immunology and ylaouar@umich.edu.
Michigan Medicine · US

Funding

Cellular and molecular mechanisms of NK cell suppressionR01AI083642 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAOUAR, YASMINA · 2011 to 2015
$1.7M
NIAID NIH HHS R01 AI083642
6 · The paper itself

Abstract

Invariant natural killer T (iNKT) cells to date represent the best example of cells known to have a hybrid function, representing both innate and adaptive immunity. Shared phenotypic similarities with NK cells together with a rapid response to a cytokine stimulus and a productive TCR engagement are the features that underline the hybrid nature of iNKT cells. Using these criteria, we provide molecular and functional evidence demonstrating that CD1d-independent (CD1d(ind)) NKT cells, a population of CD1d-unrestricted NKT cells, are endowed with a hybrid function far superior to that of iNKT cells: (i) an extensive shared program with NK cells, (ii) a closer Euclidian distance with NK cells, and (iii) the ability to respond to innate stimuli (Poly:IC) with cytotoxic potential in the same manner as NK cells identify a hybrid feature in CD1d(ind)NKT cells that truly fulfills the dual function of an NK and a T cell. Our finding that CD1d(ind)NKT cells are programmed to act like NK cells in response to innate signals while being capable of adaptive responses is unprecedented, and thus might reemphasize CD1d-unrestricted NKT cells as a subset of lymphocytes that could affect biological processes of antimicrobial and tumor immunity in a unique way.

Indexed as

Adaptive ImmunityAnimalsAntigen PresentationAntigens, CD1dCell LineageFemaleGenomicsGranzymesImmunophenotypingLymphocyte ActivationMaleMiceMice, Inbred C57BLMice, KnockoutNatural Killer T-CellsAntigens, CD1dCD1d antigen, mouseGranzymesGzmb protein, mouseCD1dgranzyme BMHCNK receptors

Identifiers

PMID25143585
PMCPMC4156687
OpenAlexW2081276932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.